Results 231 to 240 of about 14,444,288 (391)

2P-151 Function of NCS family protein calaxin in the regulation of sperm flagellar waveform(Cell biology,The 47th Annual Meeting of the Biophysical Society of Japan)

, 2009
Katsutoshi Mizuno, Kogiku Shiba, Kazuo Inaba   +2 more
openalex   +2 more sources

SYSCILIA, “A systems biology approach to dissect cilia function and its disruption in human genetic disease” [PDF]

, 2012
Ronald Roepman, Marius Ueffing, Hannie Kremer, MA Huynen, TJ Gibson, Nicholas Katsanis, G. Walz, Uwe Wolfrum, Brunella Franco, Rachel H. Giles, PL Beales, Colin A. Johnson, OE Blacque, Marco Pontoglio, François Képès, Gordana Apic, R. R. Russell, Heymut Omran   +17 more
openalex   +1 more source

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

Molecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source

Relating sparse and predictive coding to divisive normalization. [PDF]

PLoS Comput Biol
Lian Y, Burkitt AN.
europepmc   +1 more source

PrP Biology and Function [PDF]

, 2012

openalex   +1 more source

Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?

Molecular Oncology, EarlyView.
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley   +1 more source

Meeting Report on the Symposium Organized to Celebrate the 40th Anniversary of the French Society for Cell Biology. [PDF]

Biol Cell
Niedergang F, Chabrier R, Tardieux I.
europepmc   +1 more source

HER3 Comes of Age: New Insights into Its Functions and Role in Signaling, Tumor Biology, and Cancer Therapy

, 2010
Marcia R. Campbell, Dhara N. Amin, Mark M. Moasser   +2 more
openalex   +1 more source

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

Molecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen, Chung‐Teng Wang, Jia‐Ming Chang, Ai‐Li Shiau, Gia‐Shing Shieh, Yau‐Lin Tseng, Yi‐Ting Yen, Tang‐Hsiu Huang, Li‐Hsin Cheng, Yu‐Chih Wu, Chao‐Liang Wu, Bing‐Hua Su, Pensee Wu   +12 more
wiley   +1 more source

Author Correction: Stabilization mechanism accommodating genome length variation in evolutionarily related viral capsids. [PDF]

Nat Commun
Podgorski JM, Podgorski J, Abad L, Jacobs-Sera D, Freeman KG, Brown C, Hatfull GF, Luque A, White SJ.   +8 more
europepmc   +1 more source